Immix Biopharma annual current ratio
2020
2021
2022
2023
2024
2025
Immix Biopharma Current Ratio Growth & History (IMMX)
Immix Biopharma's current ratio was 10.01 for fiscal 2025.
View full Immix Biopharma company overviewImmix Biopharma annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 10.01 | 7.69 | +330.66% |
| 2024 | 2024-12-31 | 2.33 | −2.99 | −56.27% |
| 2023 | 2023-12-31 | 5.32 | −6.38 | −54.56% |
| 2022 | 2022-12-31 | 11.70 | −78.31 | −87.00% |
| 2021 | 2021-12-31 | 90.01 | 89.91 | +89031.79% |
| 2020 | 2020-12-31 | 0.10 | — | — |
Immix Biopharma quarterly current ratio
Q4.20
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 25.13 | 23.90 | +1941.19% |
| Q1 2026 | 2026-03-31 | 8.76 | 6.95 | +385.64% |
| Q4 2025 | 2025-12-31 | 10.01 | 7.69 | +330.66% |
| Q3 2025 | 2025-09-30 | 1.53 | −1.94 | −55.91% |
| Q2 2025 | 2025-06-30 | 1.23 | −5.77 | −82.42% |
| Q1 2025 | 2025-03-31 | 1.80 | −4.02 | −69.02% |
| Q4 2024 | 2024-12-31 | 2.33 | −2.99 | −56.27% |
| Q3 2024 | 2024-09-30 | 3.47 | −4.44 | −56.14% |
| Q2 2024 | 2024-06-30 | 7.00 | 0.53 | +8.22% |
| Q1 2024 | 2024-03-31 | 5.82 | −3.03 | −34.24% |
| Q4 2023 | 2023-12-31 | 5.32 | −6.38 | −54.56% |
| Q3 2023 | 2023-09-30 | 7.90 | −19.00 | −70.62% |
| Q2 2023 | 2023-06-30 | 6.47 | −13.06 | −66.86% |
| Q1 2023 | 2023-03-31 | 8.85 | −45.97 | −83.86% |
| Q4 2022 | 2022-12-31 | 11.70 | −78.31 | −87.00% |
| Q3 2022 | 2022-09-30 | 26.90 | — | — |
| Q2 2022 | 2022-06-30 | 19.53 | — | — |
| Q1 2022 | 2022-03-31 | 54.82 | — | — |
| Q4 2021 | 2021-12-31 | 90.01 | 89.91 | +89031.79% |
| Q4 2020 | 2020-12-31 | 0.10 | — | — |
Immix Biopharma current ratio trends
Over the last five fiscal years, Immix Biopharma's current ratio increased from 0.10 to 10.01, a change of 9.91. The latest reported quarter, Q2 2026, shows 25.13.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Immix Biopharma source filings ↗